Full Text View
Tabular View
No Study Results Posted
Related Studies
Isoniazid Dose Adjustment According to NAT2 Genotype (IDANAT2)
This study has been terminated.
( Enrolling participants has halted prematurely due to a low recruitment rate. )
Study NCT00571753   Information provided by University of Cologne

First Received on December 11, 2007.   Last Updated on February 25, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pulmonary Tuberculosis
Additional conditions recognized in this trial
Tuberculosis
Tuberculosis, Pulmonary
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Gram-Positive Bacterial Infections
Lung Diseases
Mycobacterium Infections
Respiratory Tract Diseases
Respiratory Tract Infections
Interventions listed in this trial
isoniazid
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antimetabolites
Antitubercular Agents
Fatty Acid Synthesis Inhibitors
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Cologne


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services